JPS6461468A - Benzohetero ring derivative - Google Patents

Benzohetero ring derivative

Info

Publication number
JPS6461468A
JPS6461468A JP21827687A JP21827687A JPS6461468A JP S6461468 A JPS6461468 A JP S6461468A JP 21827687 A JP21827687 A JP 21827687A JP 21827687 A JP21827687 A JP 21827687A JP S6461468 A JPS6461468 A JP S6461468A
Authority
JP
Japan
Prior art keywords
formula
alkyl
compound expressed
action
phenylalkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP21827687A
Other languages
English (en)
Other versions
JP2544939B2 (ja
Inventor
Shigeharu Tamada
Takafumi Fujioka
Hidenori Ogawa
Shuji Teramoto
Kazumi Kondo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Otsuka Pharmaceutical Co Ltd
Original Assignee
Otsuka Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharmaceutical Co Ltd filed Critical Otsuka Pharmaceutical Co Ltd
Priority to JP62218276A priority Critical patent/JP2544939B2/ja
Publication of JPS6461468A publication Critical patent/JPS6461468A/ja
Application granted granted Critical
Publication of JP2544939B2 publication Critical patent/JP2544939B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP62218276A 1987-09-01 1987-09-01 ベンゾヘテロ環誘導体 Expired - Fee Related JP2544939B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP62218276A JP2544939B2 (ja) 1987-09-01 1987-09-01 ベンゾヘテロ環誘導体

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP62218276A JP2544939B2 (ja) 1987-09-01 1987-09-01 ベンゾヘテロ環誘導体

Publications (2)

Publication Number Publication Date
JPS6461468A true JPS6461468A (en) 1989-03-08
JP2544939B2 JP2544939B2 (ja) 1996-10-16

Family

ID=16717327

Family Applications (1)

Application Number Title Priority Date Filing Date
JP62218276A Expired - Fee Related JP2544939B2 (ja) 1987-09-01 1987-09-01 ベンゾヘテロ環誘導体

Country Status (1)

Country Link
JP (1) JP2544939B2 (ja)

Cited By (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001053258A1 (fr) * 2000-01-20 2001-07-26 Eisai Co., Ltd. Composes azotes cycliques et compositions pharmaceutiques les contenant
WO2004014869A3 (en) * 2002-08-13 2004-06-17 Warner Lambert Co 5,6-fused 3,4-dihydropyrimidine-2-one derivatives as matrix metalloproteinase inhibitors
JP2005104931A (ja) * 2003-10-01 2005-04-21 Sumitomo Chemical Co Ltd キナゾリノン化合物の製造法
JP2006515891A (ja) * 2003-01-17 2006-06-08 シーブイ・セラピューティクス・インコーポレイテッド 循環器疾患の処置に有効な置換ヘテロ環化合物
JP2008509129A (ja) * 2004-08-06 2008-03-27 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ β−セクレターゼ（ＢＡＣＥ）のインヒビターとして有用な２−アミノ−キナゾリン誘導体
US8153793B2 (en) 2005-09-27 2012-04-10 Shionogi & Co., Ltd. Sulfonamide derivative having PGD2 receptor antagonistic activity
AU2008225766B2 (en) * 2007-03-15 2012-06-07 Novartis Ag Organic compounds and their uses
US8383637B2 (en) 2004-08-06 2013-02-26 Jansssen Pharmaceutica N.V. 2-amino-quinazoline derivatives useful as inhibitors of β-secretase (BACE)
US8426429B2 (en) 2004-08-06 2013-04-23 Jansssen Pharmaceutica N.V. 2-amino-quinazoline derivatives useful as inhibitors of β-secretase (BACE)
US8436006B2 (en) 2004-08-06 2013-05-07 Jansssen Pharmaceutica N.V. 2-amino-quinazoline derivatives useful as inhibitors of β-secretase (BACE)
US8445516B2 (en) 2004-01-29 2013-05-21 Otsuka Pharmaceutical Co., Ltd. Pharmaceutical composition for promoting angiogenesis
US8481542B2 (en) 2008-07-18 2013-07-09 Novartis Ag Pyridazinyl derivatives as smo inhibitors
EP2759540A3 (en) * 2006-08-04 2014-08-20 Universita' Degli Studi di Bari Beta-3 receptor ligands and their use in therapy
CN112566906A (zh) * 2018-07-26 2021-03-26 多曼治疗学公司 取代的喹唑啉酮衍生物和它们作为mglur4的正变构调节剂的用途
WO2021133751A1 (en) * 2019-12-23 2021-07-01 Bristol-Myers Squibb Company Substituted quinazolinyl compounds useful as t cell activators

Cited By (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001053258A1 (fr) * 2000-01-20 2001-07-26 Eisai Co., Ltd. Composes azotes cycliques et compositions pharmaceutiques les contenant
US6906072B1 (en) 2000-01-20 2005-06-14 Eisai Co., Ltd. Piperazine compound and pharmaceutical composition containing the compound
WO2004014869A3 (en) * 2002-08-13 2004-06-17 Warner Lambert Co 5,6-fused 3,4-dihydropyrimidine-2-one derivatives as matrix metalloproteinase inhibitors
JP2006515891A (ja) * 2003-01-17 2006-06-08 シーブイ・セラピューティクス・インコーポレイテッド 循環器疾患の処置に有効な置換ヘテロ環化合物
JP2005104931A (ja) * 2003-10-01 2005-04-21 Sumitomo Chemical Co Ltd キナゾリノン化合物の製造法
US8445516B2 (en) 2004-01-29 2013-05-21 Otsuka Pharmaceutical Co., Ltd. Pharmaceutical composition for promoting angiogenesis
US8426429B2 (en) 2004-08-06 2013-04-23 Jansssen Pharmaceutica N.V. 2-amino-quinazoline derivatives useful as inhibitors of β-secretase (BACE)
US8383637B2 (en) 2004-08-06 2013-02-26 Jansssen Pharmaceutica N.V. 2-amino-quinazoline derivatives useful as inhibitors of β-secretase (BACE)
US8436006B2 (en) 2004-08-06 2013-05-07 Jansssen Pharmaceutica N.V. 2-amino-quinazoline derivatives useful as inhibitors of β-secretase (BACE)
JP2008509129A (ja) * 2004-08-06 2008-03-27 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ β−セクレターゼ（ＢＡＣＥ）のインヒビターとして有用な２−アミノ−キナゾリン誘導体
US8993763B2 (en) 2005-09-27 2015-03-31 Shionogi & Co., Ltd. Sulfonamide derivative having PGD2 receptor antagonistic activity
JP5114202B2 (ja) * 2005-09-27 2013-01-09 塩野義製薬株式会社 Ｐｇｄ２受容体アンタゴニスト活性を有するスルホンアミド誘導体
US8153793B2 (en) 2005-09-27 2012-04-10 Shionogi & Co., Ltd. Sulfonamide derivative having PGD2 receptor antagonistic activity
US9440938B2 (en) 2005-09-27 2016-09-13 Shionogi & Co., Ltd. Sulfonamide derivative having PGD2 receptor antagonistic activity
EP2759540A3 (en) * 2006-08-04 2014-08-20 Universita' Degli Studi di Bari Beta-3 receptor ligands and their use in therapy
AU2008225766B2 (en) * 2007-03-15 2012-06-07 Novartis Ag Organic compounds and their uses
US8536168B2 (en) 2007-03-15 2013-09-17 Novartis Ag Benzyl and pyridinyl derivatives as modulators of the hedgehog signaling pathway
US9409871B2 (en) 2008-07-18 2016-08-09 Novartis Ag Pyridazinyl derivatives as SMO inhibitors
US8481542B2 (en) 2008-07-18 2013-07-09 Novartis Ag Pyridazinyl derivatives as smo inhibitors
CN112566906A (zh) * 2018-07-26 2021-03-26 多曼治疗学公司 取代的喹唑啉酮衍生物和它们作为mglur4的正变构调节剂的用途
JP2022511236A (ja) * 2018-07-26 2022-01-31 ドメイン・セラピューティクス 置換キナゾリノン誘導体、及びｍＧｌｕＲ４のポジティブアロステリック調節剤としてのその使用
WO2021133751A1 (en) * 2019-12-23 2021-07-01 Bristol-Myers Squibb Company Substituted quinazolinyl compounds useful as t cell activators
CN114846007A (zh) * 2019-12-23 2022-08-02 百时美施贵宝公司 可用作t细胞激活剂的经取代的喹唑啉基化合物

Also Published As

Publication number Publication date
JP2544939B2 (ja) 1996-10-16

Similar Documents

Publication Publication Date Title
JPS6461468A (en) Benzohetero ring derivative
LV11897B (lv) Silīciju saturoši fungicīdu savienojumi, to pagatavošana un agroķīmiskā un medicīniskā pielietošana
JPS649978A (en) Perfluoroalkylisoxazole derivative
IE860222L (en) Imidazole derivatives.
ATE22292T1 (de) Pyrimidoquinoxaline, ihre herstellung, ihre verwendung als arzneimittel und diese enthaltende zubereitungen.
NO153138C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive pyrimidobenzoazepinderivater.
IL75259A (en) 1-halo-1-azolyl-2,2-diarylethane derivatives,their production and their use as microbicides
GB1187680A (en) New Heterocyclic Substituted Piperazines
AU654125B2 (en) Novel diphenylthyazole derivative
EP0290285A3 (en) Bicyclic sulfonamide derivatives and their preparation, their use and formulations containing them
AU560432B2 (en) Piperazine derivatives of theobromine
JPS6461470A (en) Benzohetero ring derivative
PT75354B (en) Process for the preparation of 1-phenylindazol-3-ona compounds useful as medicines and of the intermediate products thereof
JPS5795966A (en) Novel 2(1h)-quinazolinone derivative
US4738960A (en) 1,3,4-Thiadiazole derivatives and pharmaceutical preparations useful as inhibitors for histamine-H2 receptors
ES8103040A1 (es) Un procedimiento de preparacion de una 7-acilindolin-2-ona
JPS6479155A (en) Diphenylpyridine compound
ES2021940A6 (es) Procedimiento para la preparacion de nuevos derivados de pirimidina con actividad serotoninergica.
JPS6461469A (en) Benzohetero ring derivative
EP0209089A3 (en) Use of quinazolines in the preparation of a medicament for treating and preventing ischemic cardiac disease or arrhythmia
AU535239B2 (en) Oxo-pyrido(1,2-a) thienopyrimidine compounds
ES8106143A1 (es) Procedimiento para la preparacion de derivados de cinamoil- piperidinobutirofenona
ES8106144A1 (es) Procedimiento para la preparacion de derivados de aroilete- nilpiperidinobutirofenona
JPS5690070A (en) Novel pyrimidine derivative
JPS6419030A (en) Optically active benzene derivative and its preparation

Legal Events

Date Code Title Description
LAPS Cancellation because of no payment of annual fees